---
trial_id: 849
discovery_date: 2022-05-31 22:28:46.877646
date: 2022-05-31 22:28:46.877646
title: "An International, Multicenter, Randomized, Double-Blind, Double-Masked Study of the Efficacy and Safety of BCD-132 (JSC BIOCAD, Russia) Using an Active Reference Drug (Teriflunomide) for the Treatment of Patients With Multiple Sclerosis"
summary: |
  <b>Condition</b>:    Multiple Sclerosis<br /><b>Interventions</b>:    Biological: BCD-132;   Drug: Teriflunomide<br /><b>Sponsor</b>:    Biocad<br /><b>Recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05385744?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-05-23 16:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Condition</b>:    Multiple Sclerosis<br /><b>Interventions</b>:    Biological: BCD-132;   Drug: Teriflunomide<br /><b>Sponsor</b>:    Biocad<br /><b>Recruiting</b>